Cargando…
The Cancer Drug Fraction of Metabolism Database
This study aims to create a database for quantifying the fraction of metabolism of cytochrome P450 isozymes for cancer drugs approved by the US Food and Drug Administration. A reproducible data collection protocol was developed to extract essential information, including both substrate‐depletion and...
Autores principales: | Hua, Liyan, Chiang, Chien‐Wei, Cong, Wang, Li, Jin, Wang, Xueying, Cheng, Lijun, Feng, Weixing, Quinney, Sara K., Wang, Lei, Li, Lang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6656935/ https://www.ncbi.nlm.nih.gov/pubmed/31206254 http://dx.doi.org/10.1002/psp4.12417 |
Ejemplares similares
-
How to Choose In Vitro Systems to Predict In Vivo Drug Clearance: A System Pharmacology Perspective
por: Wang, Lei, et al.
Publicado: (2015) -
Three‐Component Mixture Model‐Based Adverse Drug Event Signal Detection for the Adverse Event Reporting System
por: Zhang, Pengyue, et al.
Publicado: (2018) -
Translational Biomedical Informatics and Pharmacometrics Approaches in the Drug Interactions Research
por: Zhang, Pengyue, et al.
Publicado: (2018) -
Propensity score‐adjusted three‐component mixture model for drug‐drug interaction data mining in FDA Adverse Event Reporting System
por: Wang, Xueying, et al.
Publicado: (2019) -
Mining and visualizing high-order directional drug interaction effects using the FAERS database
por: Yao, Xiaohui, et al.
Publicado: (2020)